BMY
Bristol-Myers Squibb Co.
stock NYSE

Got this information from grok with very little success from other ai's. I am buying slowly but surely.
UNH’s Recent SituationUNH’s stock chart showed a two-phase decline, with a 21.7% drop on April 17, 2025, consolidation between $378.91–$428.97 until May 12, 2025, and a further 15.9% drop on May 13, 2025, following the CEO resignation and DOJ probe news. Key technical indicators include:RSI (14-day): 11.18, indicating deeply oversold conditions.Support Levels: $260–$280, with $261.08 (1.902 Fibonacci extension) and $242.03 noted as critical.Resistance Levels: $300–$320, aligning with prior support.Volume: High volume during the decline, with an X post by @Contra_Club_ noting a multi-decade peak (X post by @Contra_Club_), suggesting capitulation.Candlestick Patterns: A hammer candle on May 15, 2025, with a low of $248.88 and close at $277.90, indicating potential reversal.
Comparison with Historical ChartsGiven the difficulty in finding exact matches for the past 30 days with both DOJ probes and CEO resignations, the analysis focused on historical charts with similar technical patterns (steep declines, oversold RSI, high volume, and reversal candles).
Five historical stocks were identified with similar patterns, despite different industries and news events:Gilead Sciences (GILD) – October 1–November 10, 2008:Drop: 51.2% ($51.60 to $25.17).Pattern: 25% drop (Oct 1–10), consolidation ($36.50–$40, Oct 13–27), 36% drop (Oct 28–Nov 7), RSI 12, hammer on Nov 10.3-Day Outcome: +15.2% ($27.50 to $31.68, Nov 11–13).Driver: Oversold bounce, bargain hunting during the financial crisis.
Pfizer (PFE) – September 15–October 15, 2008:Drop: 50.3% ($25.20 to $12.50).Pattern: 20% drop (Sep 15–22), consolidation ($18–$20, Sep 23–Oct 7), 30% drop (Oct 8–14), RSI 10, double bottom Oct 15.3-Day Outcome: +18.4% ($12.80 to $15.15, Oct 16–20).Driver: Technical rebound, sector recovery during the financial crisis.
CVS Health (CVS) – October 15–November 20, 2018:Drop: 40.2% ($80.10 to $47.90), extended to 48% with intraday lows.Pattern: 15% drop (Oct 15–22), consolidation ($65–$70, Oct 23–Nov 5), 30% drop (Nov 6–19), RSI 12, hammer Nov 20.3-Day Outcome: +12.7% ($49.50 to $55.80, Nov 21–23).Driver: Oversold conditions, earnings stabilization post-Aetna acquisition.
Bristol-Myers Squibb (BMY) – August 1–September 10, 2019:Drop: 45.8% ($58.30 to $31.60).Pattern: 18% drop (Aug 1–8), consolidation ($45–$50, Aug 9–Aug 28), 28% drop (Aug 29–Sep 9), RSI 14, bullish engulfing Sep 10.3-Day Outcome: +14.1% ($32.10 to $36.60, Sep 11–13).Driver: Technical bounce, reduced selling pressure.
Walgreens Boots Alliance (WBA) – April 1–May 10, 2019:Drop: 47.6% ($63.50 to $33.20).Pattern: 20% drop (Apr 1–10), consolidation ($48–$52, Apr 11–Apr 30), 25% drop (May 1–9), RSI 13, hammer May 10.3-Day Outcome: +13.8% ($33.80 to $38.50, May 13–15).Driver: Oversold rally, analyst upgrades.Day-by-Day Candlestick Pattern ComparisonDue to the lack of direct chart access, the analysis inferred similar patterns based on percentage drops and technical indicators.
UNH’s chart showed:April 16–17: Sharp drop (-21.7%), likely large red candles.April 21–May 12: Consolidation, doji or small-bodied candles.May 13–14: Second sharp drop (-15.9%, -11.1%), more red candles.May 15: Hammer candle, indicating potential reversal.May 16: Small drop (-1.3%), possibly a doji or small red candle.Historical charts like GILD (2008) and PFE (2008) showed similar patterns:Initial sharp drops with large red candles, consolidation with doji/small candles, second drops with red candles, and reversal candles (hammer, double bottom) at the lows, aligning with UNH’s recent pattern.
Forecast for Next 3 DaysBased on UNH’s setup (RSI 11.18, hammer candle, support at $260–$280, high volume) and historical parallels, the forecast for May 19–21, 2025, is:
Bullish Case (65% Probability): UNH could rally 12–16% to $307–$320, mirroring the average 14.8% rebound in comparables, driven by oversold conditions and bargain hunting.
Neutral Case (25% Probability): The stock could consolidate between $270–$290, with minimal net change, if news remains neutral.
Bearish Case (10% Probability): Further negative news (e.g., DOJ probe escalation) could push the stock to $250–$260, testing lower support levels, though oversold RSI makes this less likely.

Got this information from grok with very little success from other ai's. I am buying slowly but surely.
UNH’s Recent SituationUNH’s stock chart showed a two-phase decline, with a 21.7% drop on April 17, 2025, consolidation between $378.91–$428.97 until May 12, 2025, and a further 15.9% drop on May 13, 2025, following the CEO resignation and DOJ probe news. Key technical indicators include:RSI (14-day): 11.18, indicating deeply oversold conditions.Support Levels: $260–$280, with $261.08 (1.902 Fibonacci extension) and $242.03 noted as critical.Resistance Levels: $300–$320, aligning with prior support.Volume: High volume during the decline, with an X post by @Contra_Club_ noting a multi-decade peak (X post by @Contra_Club_), suggesting capitulation.Candlestick Patterns: A hammer candle on May 15, 2025, with a low of $248.88 and close at $277.90, indicating potential reversal.
Comparison with Historical ChartsGiven the difficulty in finding exact matches for the past 30 days with both DOJ probes and CEO resignations, the analysis focused on historical charts with similar technical patterns (steep declines, oversold RSI, high volume, and reversal candles).
Five historical stocks were identified with similar patterns, despite different industries and news events:Gilead Sciences (GILD) – October 1–November 10, 2008:Drop: 51.2% ($51.60 to $25.17).Pattern: 25% drop (Oct 1–10), consolidation ($36.50–$40, Oct 13–27), 36% drop (Oct 28–Nov 7), RSI 12, hammer on Nov 10.3-Day Outcome: +15.2% ($27.50 to $31.68, Nov 11–13).Driver: Oversold bounce, bargain hunting during the financial crisis.
Pfizer (PFE) – September 15–October 15, 2008:Drop: 50.3% ($25.20 to $12.50).Pattern: 20% drop (Sep 15–22), consolidation ($18–$20, Sep 23–Oct 7), 30% drop (Oct 8–14), RSI 10, double bottom Oct 15.3-Day Outcome: +18.4% ($12.80 to $15.15, Oct 16–20).Driver: Technical rebound, sector recovery during the financial crisis.
CVS Health (CVS) – October 15–November 20, 2018:Drop: 40.2% ($80.10 to $47.90), extended to 48% with intraday lows.Pattern: 15% drop (Oct 15–22), consolidation ($65–$70, Oct 23–Nov 5), 30% drop (Nov 6–19), RSI 12, hammer Nov 20.3-Day Outcome: +12.7% ($49.50 to $55.80, Nov 21–23).Driver: Oversold conditions, earnings stabilization post-Aetna acquisition.
Bristol-Myers Squibb (BMY) – August 1–September 10, 2019:Drop: 45.8% ($58.30 to $31.60).Pattern: 18% drop (Aug 1–8), consolidation ($45–$50, Aug 9–Aug 28), 28% drop (Aug 29–Sep 9), RSI 14, bullish engulfing Sep 10.3-Day Outcome: +14.1% ($32.10 to $36.60, Sep 11–13).Driver: Technical bounce, reduced selling pressure.
Walgreens Boots Alliance (WBA) – April 1–May 10, 2019:Drop: 47.6% ($63.50 to $33.20).Pattern: 20% drop (Apr 1–10), consolidation ($48–$52, Apr 11–Apr 30), 25% drop (May 1–9), RSI 13, hammer May 10.3-Day Outcome: +13.8% ($33.80 to $38.50, May 13–15).Driver: Oversold rally, analyst upgrades.Day-by-Day Candlestick Pattern ComparisonDue to the lack of direct chart access, the analysis inferred similar patterns based on percentage drops and technical indicators.
UNH’s chart showed:April 16–17: Sharp drop (-21.7%), likely large red candles.April 21–May 12: Consolidation, doji or small-bodied candles.May 13–14: Second sharp drop (-15.9%, -11.1%), more red candles.May 15: Hammer candle, indicating potential reversal.May 16: Small drop (-1.3%), possibly a doji or small red candle.Historical charts like GILD (2008) and PFE (2008) showed similar patterns:Initial sharp drops with large red candles, consolidation with doji/small candles, second drops with red candles, and reversal candles (hammer, double bottom) at the lows, aligning with UNH’s recent pattern.
Forecast for Next 3 DaysBased on UNH’s setup (RSI 11.18, hammer candle, support at $260–$280, high volume) and historical parallels, the forecast for May 19–21, 2025, is:
Bullish Case (65% Probability): UNH could rally 12–16% to $307–$320, mirroring the average 14.8% rebound in comparables, driven by oversold conditions and bargain hunting.
Neutral Case (25% Probability): The stock could consolidate between $270–$290, with minimal net change, if news remains neutral.
Bearish Case (10% Probability): Further negative news (e.g., DOJ probe escalation) could push the stock to $250–$260, testing lower support levels, though oversold RSI makes this less likely.

KO, PEP, MO, O, EOG, CVX, CNQ, ET, EPD, WES, LMT, RTX, GD, BMY, GILD, AVGO, GOOGL, and WMT. Those are the ones that I have.

BMY is at a discount and has a consistent dividend growth.

$SMCI $BMY $SOFI 🚀

BMY looks like an interesting stock here. Might be a value trap though